Drug recall
Blood and Blood Products for Reprocessing
FDA recall event 86307 · Class II, Class III · South Texas Blood & Tissue Center
Key facts
| Event ID | 86307 |
|---|---|
| Recall numbers | B-0654-2020, B-0655-2020, B-0656-2020 |
| Recalling firm | South Texas Blood & Tissue Center |
| Product type | Biologics |
| Products | Blood and Blood Products for Reprocessing, Red Blood Cells, Leukocytes Reduced, Whole Blood CPDA-1 |
| Classification | Class II, Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products, collected from a donor who was at a higher risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed. |
| Initiation date | Jul 28, 2020 |
| Report date | Sep 16, 2020 |
| Termination date | Sep 8, 2020 |
| City | San Antonio |
| State | TX |
| Country | United States |
| FEI number | 1676815 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: